Viewing Study NCT05485350


Ignite Creation Date: 2025-12-24 @ 4:52 PM
Ignite Modification Date: 2026-01-05 @ 6:30 PM
Study NCT ID: NCT05485350
Status: UNKNOWN
Last Update Posted: 2022-08-03
First Post: 2022-07-09
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Anlotinib , Penpulimab Combined With SBRT for Metastatic Non-Small Cell Lung Cancer (NSCLC)
Sponsor:
Organization: